A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer.
about
A design for phase I trials in completely or partially ordered groups.UGT genotyping in belinostat dosingUGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.Different schedules of irinotecan administration: A meta-analysis.Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.Isotonic designs for phase I trials in partially ordered groups.Germline genetic variants with implications for disease risk and therapeutic outcomes.
P2860
Q30252706-18A18B25-0A1D-47BD-B716-97F14533EB01Q33429235-A1CB068E-3EF1-432B-8330-5B00E22B86C5Q37430719-14928CC3-201B-47D5-9B00-AB4F12FDFC45Q41934046-25390911-DC95-4640-A2DF-5B82C4027234Q42335970-FDBBAB8C-D3A8-4AB6-9896-F1D47551E2B7Q45064728-5FB91F23-CE97-40E1-B932-0146A02BB00DQ48100807-7DC3976D-614C-46D2-A99C-9B57FEB4D691
P2860
A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A UGT1A1*28 and *6 genotype-di ...... metastatic colorectal cancer.
@en
A UGT1A1*28 and *6 genotype-di ...... metastatic colorectal cancer.
@nl
type
label
A UGT1A1*28 and *6 genotype-di ...... metastatic colorectal cancer.
@en
A UGT1A1*28 and *6 genotype-di ...... metastatic colorectal cancer.
@nl
prefLabel
A UGT1A1*28 and *6 genotype-di ...... metastatic colorectal cancer.
@en
A UGT1A1*28 and *6 genotype-di ...... metastatic colorectal cancer.
@nl
P2093
P1476
A UGT1A1*28 and *6 genotype-di ...... h metastatic colorectal cancer
@en
P2093
Heung-Moon Chang
Ho-Sook Kim
Jae Lyun Lee
Jae-Gook Shin
Jung Shin Lee
Kyu-pyo Kim
Sun Jin Sym
Tae Won Kim
Yong Sang Hong
Yoon-Koo Kang
P2888
P304
P356
10.1007/S00280-013-2161-6
P577
2013-04-18T00:00:00Z